Cargando…
Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning
In various clinical studies, Hodgkin’s patients have been treated with anti-CD30 immunotherapeutic agents and have shown promising responses. One of the problems that appeared from these studies is the development of an immune response against the non-human therapeutics, which limits repeated admini...
Autores principales: | Klimka, A, Matthey, B, Roovers, R C, Barth, S, Arends, J-W, Engert, A, Hoogenboom, H R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363493/ https://www.ncbi.nlm.nih.gov/pubmed/10901379 http://dx.doi.org/10.1054/bjoc.2000.1226 |
Ejemplares similares
-
An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETÁ) is a potent immunotoxin against a Hodgkin-derived cell line
por: Klimka, A, et al.
Publicado: (1999) -
High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting.
por: Roovers, R. C., et al.
Publicado: (1998) -
Subtractive panning for the isolation of monoclonal PEPITEM peptide antibody by phage display
por: Alassiri, Mohammed, et al.
Publicado: (2023) -
Generating Recombinant Antibodies to Membrane Proteins through Phage Display
por: Huang, Renhua, et al.
Publicado: (2016) -
Profiling serum antibodies with a pan allergen phage library identifies key wheat allergy epitopes
por: Monaco, Daniel R., et al.
Publicado: (2021)